Ceefourin-1, a MRP4/ABCC4 inhibitor, induces apoptosis in AML cells enhanced by histamine
Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We als...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1867; no. 4; p. 130322 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.04.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0304-4165 1872-8006 1872-8006 |
DOI | 10.1016/j.bbagen.2023.130322 |
Cover
Loading…
Abstract | Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice.
U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice.
Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage.
These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine.
General significance:
This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies.
•Ceefourin-1, a specific MRP4 inhibitor, blocks cAMP extrusion in AML cells.•Ceefourin-1 induces apoptosis in AML cells, and not differentiation.•Histamine enhances ceefourin-1 proapoptotic capacity.•Ceefourin-1 can be administered intraperitoneally to mice without apparent toxicity. |
---|---|
AbstractList | Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. General significance: This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies. Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice.BACKGROUNDCeefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice.U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice.METHODSU937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice.Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage.RESULTSCeefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage.These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine.CONCLUSIONSThese results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine.This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies.GENERAL SIGNIFICANCEThis work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies. Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies. Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. General significance: This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies. •Ceefourin-1, a specific MRP4 inhibitor, blocks cAMP extrusion in AML cells.•Ceefourin-1 induces apoptosis in AML cells, and not differentiation.•Histamine enhances ceefourin-1 proapoptotic capacity.•Ceefourin-1 can be administered intraperitoneally to mice without apparent toxicity. |
ArticleNumber | 130322 |
Author | Yaneff, Agustín Davio, Carlos May, María Shayo, Carina Sahores, Ana González, Angela Rodríguez Fernández, Natalia Monczor, Federico Gómez, Natalia |
Author_xml | – sequence: 1 givenname: Ana surname: Sahores fullname: Sahores, Ana organization: Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, Argentina – sequence: 2 givenname: Angela Rodríguez surname: González fullname: González, Angela Rodríguez organization: Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, Argentina – sequence: 3 givenname: Agustín surname: Yaneff fullname: Yaneff, Agustín organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina – sequence: 4 givenname: María surname: May fullname: May, María organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina – sequence: 5 givenname: Natalia surname: Gómez fullname: Gómez, Natalia organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina – sequence: 6 givenname: Federico surname: Monczor fullname: Monczor, Federico organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina – sequence: 7 givenname: Natalia surname: Fernández fullname: Fernández, Natalia organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina – sequence: 8 givenname: Carlos surname: Davio fullname: Davio, Carlos organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina – sequence: 9 givenname: Carina surname: Shayo fullname: Shayo, Carina email: cshayo@dna.uba.ar organization: Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, Argentina |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36773726$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKeFN0AoSxbN1Nc_scMCaYhaQJoKhGDBynKcG8ajGXuwE6S-PYnSblhQb67l-50j65wLchZiQEJeA10Dhep6v25b-wvDmlHG18ApZ-wZWYFWrNSUVmdkRTkVpYBKnpOLnPd0OrKWL8g5r5TiilUr8rNB7OOYfCjhqrDF3bev4nrzoWlE4cPOt36I6Wq6dqPDXNhTPA0x-zy9FJu7beHwcMgFhp0NDruivS92Pg_26AO-JM97e8j46mFekh-3N9-bT-X2y8fPzWZbOs7kUDInGbCaqRq0RrTW9aJnlALwVkrGtXbU1pxpsG2nO-gZCNnTGiSAmLb8krxdfE8p_h4xD-bo8_wvGzCO2TDNBWNSVdXTqFKyglrBjL55QMf2iJ05JX-06d48JjcB7xbApZhzwt44P9jBxzAk6w8GqJlrMnuz1GTmmsxS0yQW_4gf_Z-QvV9kOOX5x2My2Xmck_cJ3WC66P9v8Bc9Bajj |
CitedBy_id | crossref_primary_10_3390_ijms25169082 |
Cites_doi | 10.1016/j.semcancer.2020.02.004 10.1016/j.phrs.2016.04.002 10.18632/oncotarget.2425 10.1038/nmeth.2089 10.1002/glia.22879 10.1007/s10495-011-0624-y 10.1016/j.bbrc.2003.12.166 10.1016/j.bcp.2018.11.005 10.3324/haematol.2021.279761 10.1038/cddis.2011.124 10.1002/ijc.24207 10.1016/j.bcp.2014.05.023 10.1016/0006-2952(95)00108-C 10.1160/TH17-04-0291 10.1124/mol.62.6.1506 10.1164/ajrccm.161.supplement_1.ltta-2 10.1074/jbc.R200029200 10.2174/0929867325666171229133259 10.1016/j.bcp.2005.12.037 10.1084/jem.20021129 10.1111/cts.12366 10.1124/mol.118.115444 10.1074/jbc.M110.166868 10.1038/bcj.2016.50 10.1074/jbc.M104833200 10.1158/1078-0432.CCR-08-0442 10.1139/y89-004 10.1038/sj.leu.2403494 10.1016/0145-2126(86)90340-1 10.1089/scd.2007.0060 10.3390/medicina58060695 10.3389/fgene.2020.00480 10.1124/mol.111.071134 10.1016/j.leukres.2007.09.015 10.3390/cancers6010436 10.1038/s41408-021-00425-3 10.1586/ehm.10.30 10.1038/sj.cdd.4400686 10.1124/jpet.118.249789 10.3390/molecules26041051 10.1016/0041-008X(92)90301-8 10.1007/978-3-642-14541-4_8 10.1111/febs.15344 10.1371/journal.pone.0225702 10.1615/CritRevEukarGeneExpr.v7.i1-2.100 |
ContentType | Journal Article |
Copyright | 2023 Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.bbagen.2023.130322 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
ExternalDocumentID | 36773726 10_1016_j_bbagen_2023_130322 S030441652300020X |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABWVN ABXDB ACDAQ ACIUM ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AFJKZ AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AATTM AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 EFKBS EFLBG 7S9 L.6 |
ID | FETCH-LOGICAL-c325t-2c52129279188eeaacf4f200113b552388c0a93281abd8d1f2145f09151143883 |
IEDL.DBID | .~1 |
ISSN | 0304-4165 1872-8006 |
IngestDate | Fri Sep 05 08:36:37 EDT 2025 Fri Sep 05 05:42:19 EDT 2025 Wed Feb 19 02:25:05 EST 2025 Tue Jul 01 00:22:17 EDT 2025 Thu Apr 24 23:03:19 EDT 2025 Sat Jan 18 16:10:40 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | AML CD RBP db-cAMP DMSO ip e-cAMP H2R Ceefourin-1 cAMP MRP4 PDE BSA i-cAMP RPMI 1640 FBS PI MK-571 Acute myeloid leukemia Apoptosis |
Language | English |
License | Copyright © 2023 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c325t-2c52129279188eeaacf4f200113b552388c0a93281abd8d1f2145f09151143883 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 36773726 |
PQID | 2775619716 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2834225766 proquest_miscellaneous_2775619716 pubmed_primary_36773726 crossref_citationtrail_10_1016_j_bbagen_2023_130322 crossref_primary_10_1016_j_bbagen_2023_130322 elsevier_sciencedirect_doi_10_1016_j_bbagen_2023_130322 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-04-01 |
PublicationDateYYYYMMDD | 2023-04-01 |
PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
PublicationYear | 2023 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Oevermann, Scheitz, Starke, Köck, Kiefer, Dölken, Niessen, Greinacher, Siegmund, Zygmunt, Kroemer, Jedlitschky, Ritter (bb0155) 2009 May 15; 124 Perez, Sklar, Chigaev, Matlawska-Wasowska (bb0170) 2021 Jan; 68 Guillemin, Raffoux, Vitoux, Kogan, Soilihi, Lallemand-Breitenbach, Zhu, Janin, Daniel, Gourmel, Degos, Dombret, Lanotte, De Thé (bb0090) 2002 Nov 18; 196 Yaneff, Sahores, Gómez, Carozzo, Shayo, Davio (bb0230) 2019; 26 Huseby, Gausdal, Keen, Kjærland, Krakstad, Myhren, Brønstad, Kunick, Schwede, Genieser, Kleppe, Døskeland (bb0100) 2011 Dec 8; 2 Schneider, Rasband, Eliceiri (bb0195) 2012 Jul; 9 Fajardo, Piazza, Tinsley (bb0070) 2014 Feb 26; 6 Becerra, Aguilera-Durán, Berumen, Romo-Mancillas, García-Alcocer (bb0005) 2021 Feb 17; 26 Vogt, Mahajan-Thakur, Wolf, Bröderdorf, Vogel, Böhm, Ritter, Gräler, Oswald, Greinacher, Kroemer, Jedlitschky, Rauch (bb0210) 2018 Jan; 118 Ramirez, Sleiman, Catchpoole, Stewart (bb0180) 2000 Jun; 7 Copsel, Bruzzone, May, Beyrath, Wargon, Cany, Russel, Shayo, Davio (bb0045) 2014 Oct 15; 5 Davio, Cricco, Bergoc, Rivera (bb0050) 1995 Jun 29; 50 Delgado, Fuentes, Fernandez-Alfonso (bb0060) 2003 Jun; 9 Zhao, Li, Du, Wu, Liu, Cui, Zhang, Gao, Keep, Xiang (bb0235) 2019 Nov 27; 14 Guo, Köck, Ritter, Chen, Grube, Jedlitschky, Illmer, Ayres, Beck, Siegmund, Ehninger, Gandhi, Kroemer, Kruh, Schaich (bb0095) 2009 Mar 1; 15 Keppler (bb0125) 2011; 201 Kobsar, Heeg, Krohne, Opitz, Walter, Böck, Gambaryan, Eigenthaler (bb0130) 2008 Feb; 17 Copsel, Garcia, Diez, Vermeulem, Baldi, Bianciotti, Russel, Shayo, Davio (bb0040) 2011 Mar 4; 286 Jördens, Keitel, Karababa, Zemtsova, Bronger, Häussinger, Görg (bb0115) 2015 Nov; 63 Jehn, Osborne (bb0105) 1997; 7 Shayo, Legnazzi, Monczor, Fernández, Riveiro, Baldi, Davio (bb0200) 2004 Feb 13; 314 Chen, Lee, Kruh (bb0025) 2001 Sep 7; 276 De Kouchkovsky, Abdul-Hay (bb0055) 2016 Jul 1; 6 Becerra, Berumen, Soto-Ontiveros, García-Alcocer (bb0010) 2022 May 24; 58 Cheung, Flemming, Watt, Masada, Yu, Huynh, Conseil, Tivnan, Polinsky, Gudkov, Munoz, Vishvanath, Cooper, Henderson, Cole, Fletcher, Haber, Norris (bb0030) 2014 Sep 1; 91 Conti, Richter, Mehats, Livera, Park, Jin (bb0035) 2003 Feb 21; 278 Green, Konig (bb0080) 2020 May 27; 11 Xie, Rich, Scheitrum, Conti, Richter (bb0225) 2011 Aug; 80 Orlando, Castillo, Medrano, Solano, Maloberti, Podesta (bb0160) 2019 Jan; 159 Wolf, Grammbauer, Palankar, Tolksdorf, Moritz, Böhm, Hasan, Hafkemeyer, Greinacher, Tzvetkov, Rauch, Jedlitschky (bb0220) 2022 Mar 17 Carozzo, Yaneff, Gómez, Di Siervi, Sahores, Diez, Attorresi, Rodríguez-González, Monczor, Fernández, Abba, Shayo, Davio (bb0020) 2019 Jul; 96 Martner, Thorén, Aurelius, Söderholm, Brune, Hellstrand (bb0140) 2010 Aug; 3 Monczor, Fernández, Riveiro, Mladovan, Baldi, Shayo, Davio (bb0145) 2006 Apr 14; 71 Fernández, Monczor, Lemos, Notcovich, Baldi, Davio, Shayo (bb0075) 2002 Dec; 62 Propper, Saunders, Salisbury, Long, O’Byrne, Braybrooke, Dowsett, Taylor, Talbot, Ganesan, Harris (bb0175) 1999 Jul; 5 Nakanishi, Takashima, Uetoko, Komori, Tamai (bb0150) 2019 Feb; 368 Wiernik, Paietta, Goloubeva, Lee, Makower, Bennett, Wade, Ghosh, Kaminer, Pizzolo, Tallman, Eastern Cooperative Oncology Group (bb0215) 2004 Oct; 18 Rodger (bb0185) 2000 Feb; 161 Rodríguez González, Sahores, Díaz-Nebreda, Yaneff, Di Siervi, Gómez, Monczor, Fernández, Davio, Shayo (bb0190) 2021 Jan; 288 Lanotte, Hermouet, Gombaud-Saintonge, Dobo (bb0135) 1986; 10 Belleville-Rolland, Sassi, Decouture, Dreano, Hulot, Gaussem, Bachelot-Loza (bb0015) 2016 May; 107 Kantarjian, Kadia, DiNardo, Daver, Borthakur, Jabbour, Garcia-Manero, Konopleva, Ravandi (bb0120) 2021 Feb 22; 11 Singh, Cadeddu, Fröbel, Wilk, Bruns, Zerbini, Prenzel, Hartwig, Brünnert, Schroeder, Lehr, Haas, Czibere (bb0205) 2011 Sep; 16 Grossman, DeLuca, Zamboni, Keenan, Patrick, Herold, van Zwieten, Zacchei (bb0085) 1992 Oct; 116 Drenberg, Hu, Li, Buelow, Orwick, Gibson, Schuetz, Sparreboom, Baker (bb0065) 2016 Feb; 9 Jones, Zamboni, Belley, Champion, Charette, Ford-Hutchinson, Frenette, Gauthier, Leger, Masson (bb0110) 1989 Jan; 67 Peng, Shi, Damaraju, Huang, Kruh, Wu, Zhou, Tiwari, Fu, Cass, Chen (bb0165) 2008 May; 32 Lanotte (10.1016/j.bbagen.2023.130322_bb0135) 1986; 10 Fajardo (10.1016/j.bbagen.2023.130322_bb0070) 2014; 6 Copsel (10.1016/j.bbagen.2023.130322_bb0045) 2014; 5 Grossman (10.1016/j.bbagen.2023.130322_bb0085) 1992; 116 Guillemin (10.1016/j.bbagen.2023.130322_bb0090) 2002; 196 Rodger (10.1016/j.bbagen.2023.130322_bb0185) 2000; 161 Copsel (10.1016/j.bbagen.2023.130322_bb0040) 2011; 286 Guo (10.1016/j.bbagen.2023.130322_bb0095) 2009; 15 Propper (10.1016/j.bbagen.2023.130322_bb0175) 1999; 5 Yaneff (10.1016/j.bbagen.2023.130322_bb0230) 2019; 26 Chen (10.1016/j.bbagen.2023.130322_bb0025) 2001; 276 Martner (10.1016/j.bbagen.2023.130322_bb0140) 2010; 3 Green (10.1016/j.bbagen.2023.130322_bb0080) 2020; 11 Wolf (10.1016/j.bbagen.2023.130322_bb0220) 2022 Shayo (10.1016/j.bbagen.2023.130322_bb0200) 2004; 314 Singh (10.1016/j.bbagen.2023.130322_bb0205) 2011; 16 Jördens (10.1016/j.bbagen.2023.130322_bb0115) 2015; 63 Orlando (10.1016/j.bbagen.2023.130322_bb0160) 2019; 159 Cheung (10.1016/j.bbagen.2023.130322_bb0030) 2014; 91 Conti (10.1016/j.bbagen.2023.130322_bb0035) 2003; 278 Ramirez (10.1016/j.bbagen.2023.130322_bb0180) 2000; 7 Wiernik (10.1016/j.bbagen.2023.130322_bb0215) 2004; 18 Jones (10.1016/j.bbagen.2023.130322_bb0110) 1989; 67 Vogt (10.1016/j.bbagen.2023.130322_bb0210) 2018; 118 Jehn (10.1016/j.bbagen.2023.130322_bb0105) 1997; 7 Becerra (10.1016/j.bbagen.2023.130322_bb0005) 2021; 26 Schneider (10.1016/j.bbagen.2023.130322_bb0195) 2012; 9 Fernández (10.1016/j.bbagen.2023.130322_bb0075) 2002; 62 Keppler (10.1016/j.bbagen.2023.130322_bb0125) 2011; 201 Nakanishi (10.1016/j.bbagen.2023.130322_bb0150) 2019; 368 Peng (10.1016/j.bbagen.2023.130322_bb0165) 2008; 32 Monczor (10.1016/j.bbagen.2023.130322_bb0145) 2006; 71 Xie (10.1016/j.bbagen.2023.130322_bb0225) 2011; 80 Becerra (10.1016/j.bbagen.2023.130322_bb0010) 2022; 58 Huseby (10.1016/j.bbagen.2023.130322_bb0100) 2011; 2 Rodríguez González (10.1016/j.bbagen.2023.130322_bb0190) 2021; 288 Perez (10.1016/j.bbagen.2023.130322_bb0170) 2021; 68 Davio (10.1016/j.bbagen.2023.130322_bb0050) 1995; 50 Zhao (10.1016/j.bbagen.2023.130322_bb0235) 2019; 14 Belleville-Rolland (10.1016/j.bbagen.2023.130322_bb0015) 2016; 107 Kantarjian (10.1016/j.bbagen.2023.130322_bb0120) 2021; 11 Carozzo (10.1016/j.bbagen.2023.130322_bb0020) 2019; 96 Delgado (10.1016/j.bbagen.2023.130322_bb0060) 2003; 9 Drenberg (10.1016/j.bbagen.2023.130322_bb0065) 2016; 9 Kobsar (10.1016/j.bbagen.2023.130322_bb0130) 2008; 17 Oevermann (10.1016/j.bbagen.2023.130322_bb0155) 2009; 124 De Kouchkovsky (10.1016/j.bbagen.2023.130322_bb0055) 2016; 6 |
References_xml | – volume: 9 start-page: 51 year: 2016 Feb end-page: 59 ident: bb0065 article-title: ABCC4 is a determinant of cytarabine-induced cytotoxicity and myelosuppression publication-title: Clin. Transl. Sci. – volume: 368 start-page: 317 year: 2019 Feb end-page: 325 ident: bb0150 article-title: Experimental evidence for Resecretion of PGE publication-title: J. Pharmacol. Exp. Ther. – volume: 18 year: 2004 Oct ident: bb0215 article-title: Phase II study of theophylline in chronic lymphocytic leukemia: a study of the eastern cooperative oncology group (E4998) publication-title: Leukemia. – volume: 63 start-page: 2092 year: 2015 Nov end-page: 2105 ident: bb0115 article-title: Multidrug resistance-associated protein 4 expression in ammonia-treated cultured rat astrocytes and cerebral cortex of cirrhotic patients with hepatic encephalopathy publication-title: Glia. – volume: 26 start-page: 1270 year: 2019 end-page: 1307 ident: bb0230 article-title: MRP4/ABCC4 as a new therapeutic target: Meta-analysis to determine cAMP binding sites as a tool for drug design publication-title: Curr. Med. Chem. – volume: 5 start-page: 9308 year: 2014 Oct 15 end-page: 9321 ident: bb0045 article-title: Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia publication-title: Oncotarget. – volume: 201 start-page: 299 year: 2011 end-page: 323 ident: bb0125 article-title: Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy publication-title: Handb. Exp. Pharmacol. – volume: 159 start-page: 52 year: 2019 Jan end-page: 63 ident: bb0160 article-title: Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression publication-title: Biochem. Pharmacol. – volume: 26 start-page: 1051 year: 2021 Feb 17 ident: bb0005 article-title: Study of endogen substrates, drug substrates and inhibitors binding conformations on MRP4 and its variants by molecular docking and molecular dynamics publication-title: Molecules. – volume: 10 start-page: 1319 year: 1986 end-page: 1326 ident: bb0135 article-title: On growth regulation of the rat promyelocytic leukemia (BNML): growth inhibition and eradication of clonogenic cells by cholera toxin publication-title: Leuk. Res. – volume: 68 start-page: 199 year: 2021 Jan end-page: 208 ident: bb0170 article-title: Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - a missed opportunity publication-title: Semin. Cancer Biol. – volume: 62 start-page: 1506 year: 2002 Dec end-page: 1514 ident: bb0075 article-title: Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation publication-title: Mol. Pharmacol. – volume: 67 start-page: 17 year: 1989 Jan end-page: 28 ident: bb0110 article-title: Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist publication-title: Can. J. Physiol. Pharmacol. – volume: 6 year: 2016 Jul 1 ident: bb0055 article-title: Acute myeloid leukemia: a comprehensive review and 2016 update publication-title: Blood Cancer J. – volume: 9 year: 2012 Jul ident: bb0195 article-title: NIH image to ImageJ: 25 years of image analysis publication-title: Nat. Methods – volume: 161 start-page: S7 year: 2000 Feb end-page: S10 ident: bb0185 article-title: From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist publication-title: Am. J. Respir. Crit. Care Med. – volume: 3 start-page: 381 year: 2010 Aug end-page: 391 ident: bb0140 article-title: Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia publication-title: Expert. Rev. Hematol. – volume: 5 start-page: 1682 year: 1999 Jul end-page: 1689 ident: bb0175 article-title: Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects publication-title: Clin. Cancer Res. – volume: 286 year: 2011 Mar 4 ident: bb0040 article-title: Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation publication-title: J. Biol. Chem. – volume: 50 start-page: 91 year: 1995 Jun 29 end-page: 96 ident: bb0050 article-title: H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers publication-title: Biochem. Pharmacol. – volume: 9 year: 2003 Jun ident: bb0060 article-title: Histamine up-regulates phosphodiesterase IV activity in U-937 cells through H2 receptor stimulation and cAMP increase publication-title: Med. Sci. Monit. – volume: 2 year: 2011 Dec 8 ident: bb0100 article-title: Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription publication-title: Cell Death Dis. – volume: 124 start-page: 2303 year: 2009 May 15 end-page: 2311 ident: bb0155 article-title: Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs publication-title: Int. J. Cancer – volume: 14 year: 2019 Nov 27 ident: bb0235 article-title: Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport publication-title: PLoS One – volume: 91 start-page: 97 year: 2014 Sep 1 end-page: 108 ident: bb0030 article-title: High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4) publication-title: Biochem. Pharmacol. – volume: 118 start-page: 132 year: 2018 Jan end-page: 142 ident: bb0210 article-title: Release of platelet-derived Sphingosine-1-phosphate involves multidrug resistance protein 4 (MRP4/ABCC4) and is inhibited by statins publication-title: Thromb. Haemost. – volume: 6 year: 2014 Feb 26 ident: bb0070 article-title: The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment publication-title: Cancers (Basel) – volume: 11 start-page: 41 year: 2021 Feb 22 ident: bb0120 article-title: Acute myeloid leukemia: current progress and future directions publication-title: Blood Cancer J. – volume: 96 start-page: 13 year: 2019 Jul end-page: 25 ident: bb0020 article-title: Identification of MRP4/ABCC4 as a target for reducing the proliferation of pancreatic ductal adenocarcinoma cells by modulating the cAMP efflux publication-title: Mol. Pharmacol. – volume: 17 start-page: 81 year: 2008 Feb end-page: 91 ident: bb0130 article-title: Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients publication-title: Stem Cells Dev. – volume: 32 start-page: 799 year: 2008 May end-page: 809 ident: bb0165 article-title: Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine publication-title: Leuk. Res. – volume: 11 start-page: 480 year: 2020 May 27 ident: bb0080 article-title: Treatment of acute myeloid leukemia in the era of genomics-achievements and persisting challenges publication-title: Front. Genet. – volume: 196 start-page: 1373 year: 2002 Nov 18 end-page: 1380 ident: bb0090 article-title: In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia publication-title: J. Exp. Med. – year: 2022 Mar 17 ident: bb0220 article-title: Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets publication-title: Haematologica. – volume: 288 start-page: 229 year: 2021 Jan end-page: 243 ident: bb0190 article-title: MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux publication-title: FEBS J. – volume: 314 start-page: 798 year: 2004 Feb 13 end-page: 804 ident: bb0200 article-title: The time-course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation publication-title: Biochem. Biophys. Res. Commun. – volume: 71 start-page: 1219 year: 2006 Apr 14 end-page: 1228 ident: bb0145 article-title: Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signalling publication-title: Biochem. Pharmacol. – volume: 276 start-page: 33747 year: 2001 Sep 7 end-page: 33754 ident: bb0025 article-title: Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine publication-title: J. Biol. Chem. – volume: 15 start-page: 1762 year: 2009 Mar 1 end-page: 1769 ident: bb0095 article-title: Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival publication-title: Clin. Cancer Res. – volume: 7 start-page: 548 year: 2000 Jun end-page: 555 ident: bb0180 article-title: Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells publication-title: Cell Death Differ. – volume: 7 start-page: 179 year: 1997 end-page: 193 ident: bb0105 article-title: Gene regulation associated with apoptosis publication-title: Crit. Rev. Eukaryot. Gene Expr. – volume: 116 start-page: 217 year: 1992 Oct end-page: 224 ident: bb0085 article-title: Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists publication-title: Toxicol. Appl. Pharmacol. – volume: 58 start-page: 695 year: 2022 May 24 ident: bb0010 article-title: Specific MRP4 inhibitor Ceefourin-1 enhances apoptosis induced by 6-Mercaptopurine in Jurkat leukemic cells, but not in Normal lymphoblast cell line CRL-1991 publication-title: Medicina (Kaunas) – volume: 107 start-page: 381 year: 2016 May end-page: 389 ident: bb0015 article-title: MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease publication-title: Pharmacol. Res. – volume: 80 year: 2011 Aug ident: bb0225 article-title: Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP publication-title: Mol. Pharmacol. – volume: 16 start-page: 889 year: 2011 Sep end-page: 901 ident: bb0205 article-title: The non-steroidal anti-inflammatory drugs Sulindac sulfide and diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway publication-title: Apoptosis. – volume: 278 start-page: 5493 year: 2003 Feb 21 end-page: 5496 ident: bb0035 article-title: Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling publication-title: J. Biol. Chem. – volume: 68 start-page: 199 year: 2021 ident: 10.1016/j.bbagen.2023.130322_bb0170 article-title: Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - a missed opportunity publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2020.02.004 – volume: 107 start-page: 381 year: 2016 ident: 10.1016/j.bbagen.2023.130322_bb0015 article-title: MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2016.04.002 – volume: 5 start-page: 9308 issue: 19 year: 2014 ident: 10.1016/j.bbagen.2023.130322_bb0045 article-title: Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia publication-title: Oncotarget. doi: 10.18632/oncotarget.2425 – volume: 9 issue: 7 year: 2012 ident: 10.1016/j.bbagen.2023.130322_bb0195 article-title: NIH image to ImageJ: 25 years of image analysis publication-title: Nat. Methods doi: 10.1038/nmeth.2089 – volume: 63 start-page: 2092 issue: 11 year: 2015 ident: 10.1016/j.bbagen.2023.130322_bb0115 article-title: Multidrug resistance-associated protein 4 expression in ammonia-treated cultured rat astrocytes and cerebral cortex of cirrhotic patients with hepatic encephalopathy publication-title: Glia. doi: 10.1002/glia.22879 – volume: 16 start-page: 889 issue: 9 year: 2011 ident: 10.1016/j.bbagen.2023.130322_bb0205 article-title: The non-steroidal anti-inflammatory drugs Sulindac sulfide and diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway publication-title: Apoptosis. doi: 10.1007/s10495-011-0624-y – volume: 314 start-page: 798 issue: 3 year: 2004 ident: 10.1016/j.bbagen.2023.130322_bb0200 article-title: The time-course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.12.166 – volume: 159 start-page: 52 year: 2019 ident: 10.1016/j.bbagen.2023.130322_bb0160 article-title: Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2018.11.005 – year: 2022 ident: 10.1016/j.bbagen.2023.130322_bb0220 article-title: Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets publication-title: Haematologica. doi: 10.3324/haematol.2021.279761 – volume: 2 issue: 12 year: 2011 ident: 10.1016/j.bbagen.2023.130322_bb0100 article-title: Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription publication-title: Cell Death Dis. doi: 10.1038/cddis.2011.124 – volume: 124 start-page: 2303 issue: 10 year: 2009 ident: 10.1016/j.bbagen.2023.130322_bb0155 article-title: Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs publication-title: Int. J. Cancer doi: 10.1002/ijc.24207 – volume: 5 start-page: 1682 issue: 7 year: 1999 ident: 10.1016/j.bbagen.2023.130322_bb0175 article-title: Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects publication-title: Clin. Cancer Res. – volume: 91 start-page: 97 issue: 1 year: 2014 ident: 10.1016/j.bbagen.2023.130322_bb0030 article-title: High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4) publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2014.05.023 – volume: 50 start-page: 91 issue: 1 year: 1995 ident: 10.1016/j.bbagen.2023.130322_bb0050 article-title: H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers publication-title: Biochem. Pharmacol. doi: 10.1016/0006-2952(95)00108-C – volume: 118 start-page: 132 issue: 1 year: 2018 ident: 10.1016/j.bbagen.2023.130322_bb0210 article-title: Release of platelet-derived Sphingosine-1-phosphate involves multidrug resistance protein 4 (MRP4/ABCC4) and is inhibited by statins publication-title: Thromb. Haemost. doi: 10.1160/TH17-04-0291 – volume: 62 start-page: 1506 issue: 6 year: 2002 ident: 10.1016/j.bbagen.2023.130322_bb0075 article-title: Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation publication-title: Mol. Pharmacol. doi: 10.1124/mol.62.6.1506 – volume: 161 start-page: S7 issue: 2 Pt 2 year: 2000 ident: 10.1016/j.bbagen.2023.130322_bb0185 article-title: From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/ajrccm.161.supplement_1.ltta-2 – volume: 278 start-page: 5493 issue: 8 year: 2003 ident: 10.1016/j.bbagen.2023.130322_bb0035 article-title: Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling publication-title: J. Biol. Chem. doi: 10.1074/jbc.R200029200 – volume: 26 start-page: 1270 issue: 7 year: 2019 ident: 10.1016/j.bbagen.2023.130322_bb0230 article-title: MRP4/ABCC4 as a new therapeutic target: Meta-analysis to determine cAMP binding sites as a tool for drug design publication-title: Curr. Med. Chem. doi: 10.2174/0929867325666171229133259 – volume: 71 start-page: 1219 issue: 8 year: 2006 ident: 10.1016/j.bbagen.2023.130322_bb0145 article-title: Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signalling publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2005.12.037 – volume: 196 start-page: 1373 issue: 10 year: 2002 ident: 10.1016/j.bbagen.2023.130322_bb0090 article-title: In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia publication-title: J. Exp. Med. doi: 10.1084/jem.20021129 – volume: 9 start-page: 51 issue: 1 year: 2016 ident: 10.1016/j.bbagen.2023.130322_bb0065 article-title: ABCC4 is a determinant of cytarabine-induced cytotoxicity and myelosuppression publication-title: Clin. Transl. Sci. doi: 10.1111/cts.12366 – volume: 96 start-page: 13 issue: 1 year: 2019 ident: 10.1016/j.bbagen.2023.130322_bb0020 article-title: Identification of MRP4/ABCC4 as a target for reducing the proliferation of pancreatic ductal adenocarcinoma cells by modulating the cAMP efflux publication-title: Mol. Pharmacol. doi: 10.1124/mol.118.115444 – volume: 286 issue: 9 year: 2011 ident: 10.1016/j.bbagen.2023.130322_bb0040 article-title: Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.166868 – volume: 6 issue: 7 year: 2016 ident: 10.1016/j.bbagen.2023.130322_bb0055 article-title: Acute myeloid leukemia: a comprehensive review and 2016 update publication-title: Blood Cancer J. doi: 10.1038/bcj.2016.50 – volume: 276 start-page: 33747 issue: 36 year: 2001 ident: 10.1016/j.bbagen.2023.130322_bb0025 article-title: Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine publication-title: J. Biol. Chem. doi: 10.1074/jbc.M104833200 – volume: 15 start-page: 1762 issue: 5 year: 2009 ident: 10.1016/j.bbagen.2023.130322_bb0095 article-title: Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-08-0442 – volume: 67 start-page: 17 issue: 1 year: 1989 ident: 10.1016/j.bbagen.2023.130322_bb0110 article-title: Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist publication-title: Can. J. Physiol. Pharmacol. doi: 10.1139/y89-004 – volume: 18 issue: 10 year: 2004 ident: 10.1016/j.bbagen.2023.130322_bb0215 article-title: Phase II study of theophylline in chronic lymphocytic leukemia: a study of the eastern cooperative oncology group (E4998) publication-title: Leukemia. doi: 10.1038/sj.leu.2403494 – volume: 10 start-page: 1319 issue: 11 year: 1986 ident: 10.1016/j.bbagen.2023.130322_bb0135 article-title: On growth regulation of the rat promyelocytic leukemia (BNML): growth inhibition and eradication of clonogenic cells by cholera toxin publication-title: Leuk. Res. doi: 10.1016/0145-2126(86)90340-1 – volume: 17 start-page: 81 issue: 1 year: 2008 ident: 10.1016/j.bbagen.2023.130322_bb0130 article-title: Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients publication-title: Stem Cells Dev. doi: 10.1089/scd.2007.0060 – volume: 58 start-page: 695 issue: 6 year: 2022 ident: 10.1016/j.bbagen.2023.130322_bb0010 article-title: Specific MRP4 inhibitor Ceefourin-1 enhances apoptosis induced by 6-Mercaptopurine in Jurkat leukemic cells, but not in Normal lymphoblast cell line CRL-1991 publication-title: Medicina (Kaunas) doi: 10.3390/medicina58060695 – volume: 11 start-page: 480 year: 2020 ident: 10.1016/j.bbagen.2023.130322_bb0080 article-title: Treatment of acute myeloid leukemia in the era of genomics-achievements and persisting challenges publication-title: Front. Genet. doi: 10.3389/fgene.2020.00480 – volume: 80 issue: 2 year: 2011 ident: 10.1016/j.bbagen.2023.130322_bb0225 article-title: Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP publication-title: Mol. Pharmacol. doi: 10.1124/mol.111.071134 – volume: 32 start-page: 799 issue: 5 year: 2008 ident: 10.1016/j.bbagen.2023.130322_bb0165 article-title: Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine publication-title: Leuk. Res. doi: 10.1016/j.leukres.2007.09.015 – volume: 6 issue: 1 year: 2014 ident: 10.1016/j.bbagen.2023.130322_bb0070 article-title: The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment publication-title: Cancers (Basel) doi: 10.3390/cancers6010436 – volume: 11 start-page: 41 issue: 2 year: 2021 ident: 10.1016/j.bbagen.2023.130322_bb0120 article-title: Acute myeloid leukemia: current progress and future directions publication-title: Blood Cancer J. doi: 10.1038/s41408-021-00425-3 – volume: 3 start-page: 381 issue: 4 year: 2010 ident: 10.1016/j.bbagen.2023.130322_bb0140 article-title: Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia publication-title: Expert. Rev. Hematol. doi: 10.1586/ehm.10.30 – volume: 7 start-page: 548 issue: 6 year: 2000 ident: 10.1016/j.bbagen.2023.130322_bb0180 article-title: Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4400686 – volume: 9 issue: 6 year: 2003 ident: 10.1016/j.bbagen.2023.130322_bb0060 article-title: Histamine up-regulates phosphodiesterase IV activity in U-937 cells through H2 receptor stimulation and cAMP increase publication-title: Med. Sci. Monit. – volume: 368 start-page: 317 issue: 2 year: 2019 ident: 10.1016/j.bbagen.2023.130322_bb0150 article-title: Experimental evidence for Resecretion of PGE2 across rat alveolar epithelium by OATP2A1/SLCO2A1-mediated transcellular transport publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.118.249789 – volume: 26 start-page: 1051 issue: 4 year: 2021 ident: 10.1016/j.bbagen.2023.130322_bb0005 article-title: Study of endogen substrates, drug substrates and inhibitors binding conformations on MRP4 and its variants by molecular docking and molecular dynamics publication-title: Molecules. doi: 10.3390/molecules26041051 – volume: 116 start-page: 217 issue: 2 year: 1992 ident: 10.1016/j.bbagen.2023.130322_bb0085 article-title: Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/0041-008X(92)90301-8 – volume: 201 start-page: 299 year: 2011 ident: 10.1016/j.bbagen.2023.130322_bb0125 article-title: Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-14541-4_8 – volume: 288 start-page: 229 issue: 1 year: 2021 ident: 10.1016/j.bbagen.2023.130322_bb0190 article-title: MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux publication-title: FEBS J. doi: 10.1111/febs.15344 – volume: 14 issue: 11 year: 2019 ident: 10.1016/j.bbagen.2023.130322_bb0235 article-title: Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport publication-title: PLoS One doi: 10.1371/journal.pone.0225702 – volume: 7 start-page: 179 issue: 1–2 year: 1997 ident: 10.1016/j.bbagen.2023.130322_bb0105 article-title: Gene regulation associated with apoptosis publication-title: Crit. Rev. Eukaryot. Gene Expr. doi: 10.1615/CritRevEukarGeneExpr.v7.i1-2.100 |
SSID | ssj0000595 |
Score | 2.4039998 |
Snippet | Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 130322 |
SubjectTerms | Acute myeloid leukemia Animals Apoptosis ATP-Binding Cassette Transporters blood cAMP caspase-3 Ceefourin-1 cell differentiation cell structures cyclic AMP histamine Histamine - pharmacology histology Humans intraperitoneal injection Leukemia, Myeloid, Acute - metabolism Mice MRP4 Multidrug Resistance-Associated Proteins myeloid leukemia subacute toxicity Western blotting |
Title | Ceefourin-1, a MRP4/ABCC4 inhibitor, induces apoptosis in AML cells enhanced by histamine |
URI | https://dx.doi.org/10.1016/j.bbagen.2023.130322 https://www.ncbi.nlm.nih.gov/pubmed/36773726 https://www.proquest.com/docview/2775619716 https://www.proquest.com/docview/2834225766 |
Volume | 1867 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhpTSX0qbNo4-gQo9R15ZkWz5uTcP2sSG0DWxOQrIk4pB6l3hzyKW_vTOWndBDGujNlscgZvT4NJr5hpD3TpjE8zxjIckdkyIxrKyVZIWvASQlZXABHfrz43x2Kr8sssUGqcZcGAyrHNb-uKb3q_XQMhm0OVk1zeQHXuoBnEC3JoKeBWawywL58z_8vgvzAPiQxZsEyVB6TJ_rY7yshUmLLKhcYFlkwfl929N98LPfho6ekacDfqTT2MXnZMO32-RxrCh5s02eVGMBtxfkrPI-oI-9ZekhNXT-_UROph-rStKmPW8szOWrQ3h0YN2OmtVytV52TQctdDr_RtGl31HfnvcxAtTeUOQmNr8Alr4kp0efflYzNlRSYLXg2ZrxGlN0S16UqVLeG1MHGTCaKhU2AwUqVScGkJxKjXXKpQH5ywNACYBjEr6KHbLZLlu_R6iH84fMjEtL52RwyvpU2VDUFs5B0MT3iRgVqOuBZhyrXVzqMZ7sQke1a1S7jmrfJ-z2r1Wk2XhAvhhto_8aLhp2ggf-fDeaUoM9UJem9cvrTvOiADCJlFr_kFFCcjyjgcxuHAe3_RV5gTV_8lf_3bfXZAvfYmDQG7K5vrr2bwHzrO1BP6gPyKPp56-z4z_ABvvU |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYoqKKXqtAXLaVG6hFrE9tJnOMSFS2wu6pakLYny45tkarNrshy4N93Jg9QDxSJW2SPJWtmPP48mQchX5wwkedpwkKUOiZFZFheKskyXwJIivLgAjr0Z_N0cinPFsligxRDLgyGVfa2v7PprbXuR0Y9N0erqhr9wJ96ACfQrYmgZ_GMbGF1KlD2rfHp-WR-b5CTtvkK0jNcMGTQtWFe1sK5xUKoXGBnZMH5QzfUQwi0vYlOXpGXPYSk426XO2TD17vkeddU8naXbBdDD7fX5GfhfUA3e83iI2ro7Ps3ORofF4WkVX1VWTjO10fw6UDADTWr5Wq9bKoGRuh4NqXo1W-or6_aMAFqbymWJzZ_AJm-IZcnXy-KCeubKbBS8GTNeIlZujnP8lgp740pgwwYUBULmwAPlSojA2BOxcY65eKAJcwDoAlAZBJmxVuyWS9r_55QD08QmRgX587J4JT1sbIhKy08hWCI7xExMFCXfaVxbHjxWw8hZb90x3aNbNcd2_cIu1u16iptPEKfDbLR_2iMhsvgkZWHgyg1yAN5aWq_vGk0zzLAk1hV6z80SkiOzzSgedfpwd1-RZph25_0w5P39plsTy5mUz09nZ9_JC9wposT2ieb6-sb_wkg0Noe9Cr-F2pM_oU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ceefourin-1%2C+a+MRP4%2FABCC4+inhibitor%2C+induces+apoptosis+in+AML+cells+enhanced+by+histamine&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Sahores%2C+Ana&rft.au=Gonz%C3%A1lez%2C+Angela+Rodr%C3%ADguez&rft.au=Yaneff%2C+Agust%C3%ADn&rft.au=May%2C+Mar%C3%ADa&rft.date=2023-04-01&rft.issn=0304-4165&rft_id=info:doi/10.1016%2Fj.bbagen.2023.130322&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |